Advanced search
Publication Cover
Journal of Chemotherapy Volume 29, 2017 - Issue 1
Submit an article Journal homepage
137
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials

Andreas SashegyiEli Lilly and Company, Indianapolis, IN, USA
,
Yawei ZhangEli Lilly and Company, Bridgewater, NJ, USACorrespondence[email protected]
,
Yong LinEli Lilly and Company, Indianapolis, IN, USA
,
Polina BinderEli Lilly and Company, Bridgewater, NJ, USA
&
David FerryEli Lilly and Company, Bridgewater, NJ, USA
Pages 62-64 | Received 04 Aug 2015, Accepted 21 Oct 2015, Published online: 06 Feb 2016

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.